# PMCF Study to Evaluate Performance and Safety of "Hyaluronic Acid (HA)-Based Eyedrops" Used to Relieve Dry Eye Symptoms

> **NCT05807360** · NA · COMPLETED · sponsor: **C.O.C. Farmaceutici S.r.l.** · enrollment: 160 (actual)

## Conditions studied

- Dry Eye
- Dry Eye Disease
- Kerato Conjunctivitis Sicca

## Interventions

- **DEVICE:** Hyaluronic acid eye drops

## Key facts

- **NCT ID:** NCT05807360
- **Lead sponsor:** C.O.C. Farmaceutici S.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-24
- **Primary completion:** 2023-06-05
- **Final completion:** 2023-06-05
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05807360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05807360, "PMCF Study to Evaluate Performance and Safety of "Hyaluronic Acid (HA)-Based Eyedrops" Used to Relieve Dry Eye Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05807360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*